Trials / Completed
CompletedNCT02459080
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
A Phase 3, 12-week, Randomized, Double-blind Placebo-controlled Parallel Group Study of Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 619 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to measure the effectiveness and safety of TD 4208, an investigational drug being developed to treat people with moderate to very severe COPD, compared to placebo, a treatment without activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-4208 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-08-01
- Completion
- 2016-09-01
- First posted
- 2015-06-01
- Last updated
- 2022-02-24
- Results posted
- 2018-12-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02459080. Inclusion in this directory is not an endorsement.